Human Urine Samples
Access human urine samples from difficult-to-reach or rare patient populations,
including event-based or longitudinal collection.
Urine Specimen Collection
With Sanguine, you get access to a nationwide reach of patient communities and unparalleled biospecimen collection capabilities to obtain human urine samples for a diverse range of translational disease research needs.
Our unique patient-centric engagement model enhances the accuracy and timeliness of information on health status, disease activity, and other patient data so you can make informed study design decisions and conduct your research confidently.
Looking for other sample types? We can deliver several other human biofluids and tissue samples, such as whole blood, PBMCs, serum, and hair.
Our patient-centric approach translates into an enhanced ability to recruit and retain study participants, enabling access to difficult-to-reach patient populations and challenging sample collection timepoints.
Longitudinal and event-based biospecimen and data collection
Same-day sample collection and delivery
Nationwide patient member community to meet complex inclusion/exclusion criteria
Medical record-verified eligibility and pre-screening
Access to electronic medical records, health histories, patient-reported datasets
Long-term follow-up with study participants
We Specialize in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 60,000 total members ready to advance science and medicine for the conditions they live with.
Get Samples for My Research
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, International Conference on Harmonization (ICH) and Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.